BioLife Solutions (BLFS) News Today $25.82 -0.59 (-2.23%) As of 03/25/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Intech Investment Management LLC Grows Stake in BioLife Solutions, Inc. (NASDAQ:BLFS)Intech Investment Management LLC lifted its position in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 164.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,985 shares of the medical equipment provider's stock after purchaMarch 24 at 4:06 AM | marketbeat.comProficio Capital Partners LLC Takes $638,000 Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Proficio Capital Partners LLC bought a new stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 24,584 shares of the medical equipment provideMarch 24 at 3:14 AM | marketbeat.comBioLife Solutions (NASDAQ:BLFS) versus NeurAxis (NASDAQ:NRXS) Head-To-Head AnalysisMarch 24 at 1:53 AM | americanbankingnews.comBioLife Solutions, Inc. (NASDAQ:BLFS) Shares Acquired by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. raised its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 8.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 346,421 shares of the mMarch 23 at 3:02 AM | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Raised to "Hold" at StockNews.comMarch 21, 2025 | americanbankingnews.comBioLife Solutions (NASDAQ:BLFS) Stock Rating Upgraded by StockNews.comStockNews.com upgraded shares of BioLife Solutions from a "sell" rating to a "hold" rating in a research report on Wednesday.March 20, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sarah Aebersold Sells 2,695 SharesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 2,695 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $25.44, for a total value of $68,560.80. Following the completion of the sale, the insider now directly owns 43,165 shares of the company's stock, valued at $1,098,117.60. The trade was a 5.88 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.March 20, 2025 | marketbeat.comSarah Aebersold Sells 2,695 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 2,695 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $25.44, for a total transaction of $68,560.80. Following the completion of the transaction, the insider now owns 43,165 shares in the company, valued at approximately $1,098,117.60. This represents a 5.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.March 19, 2025 | marketbeat.comSarah Aebersold Sells 5,632 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 5,632 shares of BioLife Solutions stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $24.96, for a total transaction of $140,574.72. Following the sale, the insider now owns 45,860 shares of the company's stock, valued at approximately $1,144,665.60. This represents a 10.94 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.March 19, 2025 | marketbeat.comWilliam Blair Investment Management LLC Trims Position in BioLife Solutions, Inc. (NASDAQ:BLFS)William Blair Investment Management LLC decreased its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 20.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 910,348 shares of the medical equipment provider's stMarch 19, 2025 | marketbeat.comBioLife Solutions Appoints Cathy Coste as Director and Audit Committee ChairMarch 18, 2025 | prnewswire.comRoyce & Associates LP Has $20.18 Million Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)Royce & Associates LP lessened its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 5.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 777,282 shares of the medical equipment proMarch 17, 2025 | marketbeat.comRaymond James Financial Inc. Takes $20.66 Million Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Raymond James Financial Inc. bought a new stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 795,998 shares of the medical equipment provider's stock, valued at approximately $20,664,000. RMarch 17, 2025 | marketbeat.comVictory Capital Management Inc. Boosts Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)Victory Capital Management Inc. raised its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 422.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 218,962 shares of the medical equMarch 16, 2025 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Trading Down 2.6% on Insider SellingMarch 16, 2025 | americanbankingnews.comBioLife Solutions (NASDAQ:BLFS) Stock Price Down 2.6% on Insider SellingBioLife Solutions (NASDAQ:BLFS) Stock Price Down 2.6% After Insider SellingMarch 15, 2025 | marketbeat.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sells 1,091 Shares of StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 1,091 shares of BioLife Solutions stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $25.00, for a total transaction of $27,275.00. Following the completion of the sale, the insider now owns 58,816 shares in the company, valued at $1,470,400. The trade was a 1.82 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.March 14, 2025 | marketbeat.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) CMO Sells 1,577 Shares of StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CMO Todd Berard sold 1,577 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $25.00, for a total value of $39,425.00. Following the transaction, the chief marketing officer now owns 104,961 shares of the company's stock, valued at $2,624,025. The trade was a 1.48 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.March 14, 2025 | marketbeat.comAby J. Mathew Sells 1,597 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 1,597 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $25.00, for a total transaction of $39,925.00. Following the completion of the transaction, the executive vice president now owns 260,601 shares in the company, valued at $6,515,025. The trade was a 0.61 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.March 14, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) CFO Troy Wichterman Sells 4,151 SharesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 4,151 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $25.00, for a total value of $103,775.00. Following the completion of the sale, the chief financial officer now owns 116,809 shares of the company's stock, valued at $2,920,225. This trade represents a 3.43 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.March 14, 2025 | marketbeat.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sells 1,091 Shares of StockMarch 14, 2025 | insidertrades.comQ1 EPS Estimate for BioLife Solutions Raised by AnalystBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Research analysts at HC Wainwright lifted their Q1 2025 earnings estimates for shares of BioLife Solutions in a research report issued on Wednesday, March 5th. HC Wainwright analyst Y. Chen now anticipates that the medical equipment provider wMarch 10, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Rating of "Buy" by BrokeragesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) has been assigned a consensus recommendation of "Buy" from the seven research firms that are presently covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy rating. The average 12-month pricMarch 9, 2025 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Given New $30.00 Price Target at HC WainwrightHC Wainwright boosted their price objective on shares of BioLife Solutions from $27.00 to $30.00 and gave the company a "buy" rating in a research report on Thursday.March 7, 2025 | marketbeat.comQ1 EPS Estimate for BioLife Solutions Increased by AnalystBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Research analysts at Northland Capmk boosted their Q1 2025 earnings per share estimates for shares of BioLife Solutions in a research note issued on Monday, March 3rd. Northland Capmk analyst C. Byrnes now forecasts that the medical equipmentMarch 7, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Stake Cut by Geneva Capital Management LLCGeneva Capital Management LLC cut its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 1.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 852,741 shares of the medical equipment provider'March 7, 2025 | marketbeat.comTodd Berard Sells 424 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CMO Todd Berard sold 424 shares of BioLife Solutions stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $25.46, for a total value of $10,795.04. Following the sale, the chief marketing officer now owns 106,538 shares of the company's stock, valued at approximately $2,712,457.48. This trade represents a 0.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.March 6, 2025 | marketbeat.comAby J. Mathew Sells 425 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 425 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $25.46, for a total value of $10,820.50. Following the sale, the executive vice president now owns 262,198 shares in the company, valued at $6,675,561.08. This represents a 0.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.March 6, 2025 | marketbeat.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells 660 Shares of StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 660 shares of the business's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $25.46, for a total value of $16,803.60. Following the transaction, the chief financial officer now directly owns 120,960 shares of the company's stock, valued at $3,079,641.60. The trade was a 0.54 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.March 6, 2025 | marketbeat.comNorthland Capmk Analysts Boost Earnings Estimates for BLFSBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Investment analysts at Northland Capmk increased their Q3 2025 earnings estimates for shares of BioLife Solutions in a research note issued to investors on Monday, March 3rd. Northland Capmk analyst C. Byrnes now anticipates that the medical eMarch 6, 2025 | marketbeat.comTodd Berard Sells 424 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockMarch 6, 2025 | insidertrades.comLake Street Sticks to Its Buy Rating for BioLife Solutions (BLFS)March 6, 2025 | markets.businessinsider.comBioLife Solutions price target raised to $30 from $27 at H.C. WainwrightMarch 6, 2025 | msn.comBioLife Solutions (NASDAQ:BLFS) Announces Earnings Results, Beats Expectations By $0.32 EPSBioLife Solutions (NASDAQ:BLFS - Get Free Report) announced its earnings results on Monday. The medical equipment provider reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.32. BioLife Solutions had a negative net margin of 38.98% and a negative return on equity of 6.61%. The company had revenue of $22.71 million during the quarter, compared to analysts' expectations of $21.73 million. During the same quarter in the previous year, the business posted ($0.21) earnings per share.March 4, 2025 | marketbeat.comBioLife Solutions stock surges on strong Q4 results, upbeat guidanceMarch 3, 2025 | in.investing.comBioLife Solutions projects $95.5M-$99M revenue for 2025 with 16%-20% growthMarch 3, 2025 | msn.comBioLife Solutions (NASDAQ:BLFS) Shares Gap Up - Here's What HappenedBioLife Solutions (NASDAQ:BLFS) Shares Gap Up - Should You Buy?March 3, 2025 | marketbeat.comBioLife Solutions, Inc.: BioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | finanznachrichten.deBioLife Solutions sees FY25 revenue $95.5M-$99M, consensus $95.46MMarch 3, 2025 | markets.businessinsider.comCraig-Hallum Keeps Their Buy Rating on BioLife Solutions (BLFS)March 3, 2025 | markets.businessinsider.comBioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | prnewswire.comPrincipal Financial Group Inc. Boosts Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Principal Financial Group Inc. grew its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 28.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 244,247 shares of the medical equipment prMarch 3, 2025 | marketbeat.comBioLife Solutions Q4 2024 Earnings PreviewMarch 1, 2025 | msn.comBioLife Solutions, Inc. (NASDAQ:BLFS) Holdings Lifted by Mutual of America Capital Management LLCMutual of America Capital Management LLC boosted its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 31.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 521,937 shares of theMarch 1, 2025 | marketbeat.comNew York State Common Retirement Fund Has $6.76 Million Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)New York State Common Retirement Fund increased its position in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 4.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 260,315 shares of the medical equipment provider's stock after purchasing an additiFebruary 27, 2025 | marketbeat.comBioLife Solutions (BLFS) Projected to Post Quarterly Earnings on MondayBioLife Solutions (NASDAQ:BLFS) will be releasing earnings before the market opens on Monday, March 3. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=668783)February 24, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Reduces Stock Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)Allspring Global Investments Holdings LLC decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 14.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 95,332 shares of the medical equipment pFebruary 22, 2025 | marketbeat.comBioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025February 20, 2025 | prnewswire.comBioLife Solutions, Inc. (NASDAQ:BLFS) Stake Raised by Peregrine Capital Management LLCPeregrine Capital Management LLC lifted its position in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 18.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 352,205 shares of the medical equipment provider's stock afFebruary 18, 2025 | marketbeat.comBiolife Solutions' chief quality and operations officer sells $2,070 in stockFebruary 16, 2025 | msn.com Remove Ads Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address BLFS Media Mentions By Week BLFS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLFS News Sentiment▼1.440.77▲Average Medical News Sentiment BLFS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLFS Articles This Week▼114▲BLFS Articles Average Week Remove Ads Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Inari Medical News Today PROCEPT BioRobotics News Today iRhythm Technologies News Today Envista News Today TransMedics Group News Today Soleno Therapeutics News Today Enovis News Today LivaNova News Today NovoCure News Today Warby Parker News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLFS) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | SponsoredElon x DOGE = Government backed Smokescreen???While the mainstream media obsesses over Elon's new Department of Government Efficiency... A much BIGGER st...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
